Unintentional lethal overdose with metildigoxin in a 36-week-old infant - post mortem tissue distribution of metildigoxin and its metabolites by liquid chromatography tandem mass spectrometry

Forensic Science International

Volumn 241, Issue , 2014, Pages

  Hess, Cornelius ^a   Brockmann, Christopher ^a   Doberentz, Elke ^a   Madea, Burkhard ^a   Musshoff, Frank ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b Forensic Toxicological Center FTC   (Germany)

Author keywords

Cardiac glycosides; Digoxin; Mass spectrometry; Metildigoxin; Overdose

Indexed keywords

2 ETHYLIDEN 1,5 DIMETHYL 3,3 DIPHENYL PYRROLIDIN; BETA METILDIGOXIN; DIGOXIN; DIGOXINGENIN; DIGOXINGENIN MONODIGITOXOSID; DRUG METABOLITE; METHADONE; METILDIGOXIN; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; DIGOXIGENIN; DIGOXIGENIN-MONO(DIGITOXOSIDE);

ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; DIGITALIS INTOXICATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG OVERDOSE; DRUG STRUCTURE; DRUG TISSUE LEVEL; FORENSIC TOXICOLOGY; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; INFANT; LETHALITY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEDICATION ERROR; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RESUSCITATION; STENT; STOMACH CONTENT; TOXICITY TESTING; ANALOGS AND DERIVATIVES; HYPERTENSION, PULMONARY; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

CARDIOTONIC AGENTS; CHROMATOGRAPHY, LIQUID; DIGOXIGENIN; DIGOXIN; DRUG OVERDOSE; FORENSIC TOXICOLOGY; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; MEDICATION ERRORS; MEDIGOXIN; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84904304555     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.05.013     Document Type: Article

References (25)

1. Mitamura K., Horikawa A., Yamane Y., Ikeda Y., Fujii Y., Shimada K. Determination of digoxin in human serum using stable isotope dilution liquid chromatography/electrospray ionization/tandem mass spectrometry. Biol. Pharm. Bull. 2007, 30:1653-1656.
2. Melo P., Machado R., Teixeira H.M. Analysis of digoxin and metildigoxin in whole blood using solid-phase extraction and liquid chromatography tandem mass spectrometry. Int. J. Anal. Chem. 2012, 975824.
3. Musshoff F., Trafkowski J., Kuepper U., Madea B. An automated and fully validated LC-MS/MS procedure for the simultaneous determination of 11 opioids used in palliative care, with 5 of their metabolites. J. Mass Spectrom. 2006, 41:633-640.
4. Soler P., Garcia Y., Zilleruelo R. Serum digoxin in children treated with beta methyl digoxin. Rev. Chil. Pediatr. 1991, 62:350-354.
5. Rameis H., Bonelli J., Waginger H., Hruby K. Pharmacokinetics of beta-methyldigoxin and beta-acetyldigoxin in patients with cirrhosis of the liver. Wien. Klin. Wochenschr. 1981, 93:572-576.
6. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. J. Am. Med. Assoc. 2003, 19(289):871-878.
7. Terra S.G., Washam J.B., Dunham G.D., Gattis W.A. Therapeutic range of digoxin's efficacy in heart failure: what is the evidence?. Pharmacotherapy 1999, 19:1123-1126.
8. Panisset J.C., Biron P., Tremblay G., Nadeau R., Proulx A. Comparative bioavailability of two oral preparations of digoxin in healthy volunteers. Can. Med. Assoc. J. 1973, 109:700-702.
9. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. J. Am. Med. Assoc. 2003, 19(289):871-878.
10. Soler P., Garcia Y., Zilleruelo R., et al. Serum digoxin in children treated with beta methyl digoxin. Rev. Chil. Pediatr. 1991, 62:350-354.
11. Smith T.W., Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J. Clin. Invest. 1970, 49:2377-2386.
12. Eyal D., Molczan K.A., Carroll L.S. Digoxin toxicity: pediatric survival after asystolic arrest. Clin. Toxicol. (Phila.) 2005, 43:51-54.
13. Hobson J.D., Zettner A. Digoxin serum half-life following suicidal digoxin poisoning. J. Am. Med. Assoc. 1973, 223:147-149.
14. Carney M.W., Rapp S., Pearce K. Digoxin toxicity presenting with psychosis in a patient with chronic phobic anxiety. Clin. Neuropharmacol. 1985, 8:193-195.
15. Moffat A.C., David Osselton M., Widdop B. Clarke's Analysis of Drugs and Poisons 2004, vol. 2. Pharmaceutical Press. 3rd ed.
16. Doherty J.E., Flanigan W.J., Murphy M.L., et al. Tritiated digoxin. XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers. Circulation 1970, 42:867-873.
17. Gault M.H., Sugden D., Maloney C., Ahmed M., Tweeddale M. Biotransformation and elimination of digoxin with normal and minimal renal function. Clin. Pharmacol. Ther. 1979, 25:499-513.
18. DiMaio V.J., Garriott J.C., Putnam R. Digoxin concentrations in postmortem specimens after overdose and therapeutic use. J. Forensic Sci. 1975, 20:340-347.
19. Karjalainen J., Ojala K., Reissell P. Tissue concentrations of digoxin in an autopsy material. Acta Pharmacol. Toxicol. (Copenh.) 1974, 34:385-390.
20. Holt D.W., Benstead J.G. Postmortem assay of digoxin by radioimmunoassay. J. Clin. Pathol. 1975, 28:483-486.
21. Vorpahl T.E., Coe J.I. Correlation of antemortem and postmortem digoxin levels. J. Forensic Sci. 1978, 23:329-334.
22. Baselt E. Disposition of toxic drugs and chemicals in man 2011, Biomedical Publications, Seal Beach, CA. 9th ed.
23. Andersson K.E., Bertler A., Wettrell G. Post-mortem distribution and tissue concentrations of digoxin in infants and adults. Acta Paediatr. Scand. 1975, 64:497-504.
24. Aderjan R., Doster S., Petri H., Schmidt G. Cardiac glycosides and metabolites-problems of recovery in tissue extracts. Separation of visible substance spots in the nanogram range. Z. Rechtsmed. 1979, 83:201-207.
25. Vorpahl T.E., Coe J.I. Correlation of antemortem and postmortem digoxin levels. J. Forensic Sci. 1978, 23:329-334.